Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DYDC2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | RPL7A | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | TLX1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
mRNA | LGMN | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
mRNA | TNFRSF4 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | CD200 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | PCDHB11 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | MMP2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | ZNF92 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | LTA | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |